Experiences of Migraine and Erenumab Treatment in Japan: Qualitative Interviews with Clinical Trial Participants.

Background: In Japan, migraine is estimated to affect 6–8.6% of the population, and the burden of migraine and barriers to migraine care are substantial. Although new preventive treatments are available for migraine, there is limited qualitative information about the lived experience of adults with...

Descripción completa

Detalles Bibliográficos

Publicado en:	Patient Vol. 19; no. 5; pp. 699 - 710
Autores principales:	Dias-Barbosa, Carla, Igarashi, Hisaka, Duenas, Ashley, Hareendran, Asha, Kitamura, Shigekazu, Tanaka, Shigeya, Sanno, Naoko, Doi, Hikaru, Nagamitsu, Tsutomu, Tatsuoka, Yoshihisa, Matsumori, Yasuhiko, Hasebe, Miki, Takeshima, Takao
Formato:	research tables/charts Journal Article
Publicado:	Springer Nature Sep2026
Acceso en línea:	Ver este registro en EBSCOhost